During the past decade, Centro Javeriano de Oncología conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Javeriano de Oncología" are "Malignant Melanoma" (1 trials), "Multiple Sclerosis" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Centro Javeriano de Oncología" in a lesser frequency.

Most popular intervention types in "Centro Javeriano de Oncología" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy (Induction Period)" (1 trials), "Ocrelizumab" (1 trials), "Rituximab" (1 trials) and "Vemurafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Javeriano de Oncología" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centro Javeriano de Oncología". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro Javeriano de Oncología, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Javeriano de Oncología, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".